Researchers continue to excited about Retatrutide , a novel dual treatment showing promising results in initial trials for weight loss . It acts by targeting both pathways : GLP-1 and GIP, which , when engaged , assist influence hunger and enhance calorie burn. Initial findings demonstrate noteworthy weight management and possible benefits for peop